ZBHNYSEOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
ZIMMER BIOMET HOLDINGS, INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026
$94.99+0.01 (+0.01%)
Close on Oct 19, 2026
- Market cap
- $18.31B
- P/E (TTM)
- 23.1
- Dividend yield
- 1.01%
ZIMMER BIOMET HOLDINGS, INC. revenue by segment
By business segment
By product or service
| Revenue | TTM Q2 26 | TTM Q1 26 | TTM Q4 25 | TTM Q3 25 | TTM Q2 25 | TTM Q1 25 | TTM Q4 24 | TTM Q3 24 | TTM Q2 24 | TTM Q1 24 | TTM Q4 23 | TTM Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Knees [Member] | $3.36B | $3.36B | $3.32B | $3.25B | $3.20B | $3.18B | $3.17B | $3.13B | $3.09B | $3.06B | $3.04B | $2.99B | 39.5% | +4.9% |
| S.E.T [Member] | $2.28B | $2.24B | $2.15B | $2.05B | $1.96B | $1.88B | $1.87B | $1.83B | $1.80B | $1.77B | $1.75B | $1.72B | 26.8% | +15.9% |
| Hips [Member] | $2.15B | $2.12B | $2.09B | $2.06B | $2.03B | $2.00B | $2.00B | $1.98B | $1.97B | $1.97B | $1.97B | $1.95B | 25.2% | +5.7% |
| Technology & Data, Bone Cement and Surgical [Member] | $722.20M | $687.40M | $665.60M | $650.50M | $632.60M | $632.90M | $640.30M | – | – | – | – | – | 8.5% | +14.2% |
| Other [Member] | – | – | – | – | – | – | – | $649.40M | $664.80M | $651.10M | $636.00M | $611.00M | – | – |
By region
| Revenue | TTM Q2 26 | TTM Q1 26 | TTM Q4 25 | TTM Q3 25 | TTM Q2 25 | TTM Q1 25 | TTM Q4 24 | TTM Q3 24 | TTM Q2 24 | TTM Q1 24 | TTM Q4 23 | TTM Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Americas [Member] | $5.35B | $5.28B | $5.14B | $5.02B | $4.90B | $4.82B | $4.79B | $4.73B | $4.71B | $4.67B | $4.62B | $4.56B | 62.9% | +9.1% |
| United States | $4.93B | $4.86B | $4.76B | $4.63B | $4.52B | $4.45B | $4.44B | $4.39B | $4.37B | $4.33B | $4.29B | $4.24B | 57.9% | +9.0% |
| EMEA [Member] | $1.89B | $1.87B | $1.83B | $1.75B | $1.71B | $1.69B | $1.69B | $1.68B | $1.64B | $1.61B | $1.59B | $1.54B | 22.2% | +10.1% |
| Asia Pacific [Member] | $1.27B | $1.26B | $1.26B | $1.24B | $1.22B | $1.20B | $1.19B | $1.18B | $1.17B | $1.17B | $1.18B | $1.17B | 15.0% | +4.5% |
| International [Member] | – | – | – | $3.38B | $3.31B | $3.25B | $3.24B | $3.21B | $3.16B | $3.12B | $3.11B | $3.04B | – | – |
From the segment and revenue-disaggregation notes of Zimmer Biomet's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.